Brand Name

Mycobutin

Generic Name
Rifabutin
View Brand Information
FDA approval date: December 23, 1992
Classification: Rifamycin Antimycobacterial
Form: Capsule

What is Mycobutin (Rifabutin)?

Rifabutin Capsules are indicated for the prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infection.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

Comparison of Susceptibility Testing Guided Versus Empirical Therapy for the Third-line Eradication of H. Pylori- a Multicenter Randomized Trial

Methods: This will be a multi-center, open labeled trial Patients: 360 patients with failure to H. pylori eradication for at least two times will be enrolled Determination of antibiotic resistance of H. pylori: Agar dilution test will be used to determine the minimum inhibitory concentrations of levofloxacin, tetracycline, rifabutin, and clarithromycin to guide the selection of antibiotics. Treatment regim...

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT)

Summary: Mycobacterium abscessus (MABS) is a group of rapid-growing, multi-drug resistant non-tuberculous mycobacteria (NTM) causing infections in humans. MABS pulmonary disease (MABS-PD) can result in significant morbidity, increased healthcare utilisation, accelerated lung function decline, impaired quality of life, more challenging lung transplantation, and increased mortality. While the overall numbers...